Maharashtra, India

Vikas Padalkar

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Generics (UK) Limited. Active years: 2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Vikas Padalkar. Retrieved from https://idiyas.com/inventor/vikas-padalkar

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2014

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Vikas Padalkar: Innovator in Pharmaceutical Chemistry

Introduction

Vikas Padalkar is a notable inventor based in Maharashtra, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of processes for preparing important medicinal compounds.

Latest Patents

Vikas Padalkar holds a patent for a process related to the preparation of bosentan. This invention pertains to a novel intermediate that is useful in the synthesis of bosentan, a medication used in the treatment of endothelin-receptor mediated disorders. The patent outlines the processes for preparing both the intermediate and bosentan, as well as compositions that include bosentan.

Career Highlights

Vikas Padalkar is associated with Generics (UK) Limited, where he applies his expertise in pharmaceutical development. His work focuses on innovative solutions that enhance the efficacy of treatments for various medical conditions.

Collaborations

He collaborates with talented professionals such as Abhay Gaitonde and Bindu Manojkumar, contributing to a dynamic research environment that fosters innovation.

Conclusion

Vikas Padalkar's contributions to pharmaceutical chemistry, particularly through his patent on bosentan preparation, highlight his role as an innovator in the field. His work continues to impact the development of effective treatments for serious health conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…